1309982-38-4 Usage
General Description
5-(tert-Butoxycarbonyl)pyridine-3-boronic acid pinacol ester is a chemical compound used in organic synthesis and medicinal chemistry. It is a boronic acid ester derivative containing a pyridine ring and a tert-butoxycarbonyl (Boc) group. 5-(TERT-BUTOXYCARBONYL)PYRIDINE-3-BORONIC ACID PINACOL ESTER is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and materials. The boronic acid functional group allows for the formation of stable complexes with reactive substrates, making it a valuable tool in Suzuki-Miyaura cross-coupling reactions and other carbon-carbon bond forming reactions. Additionally, the Boc-protected pyridine moiety provides a versatile handle for further derivatization, making it a valuable intermediate in the preparation of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 1309982-38-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,0,9,9,8 and 2 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1309982-38:
(9*1)+(8*3)+(7*0)+(6*9)+(5*9)+(4*8)+(3*2)+(2*3)+(1*8)=184
184 % 10 = 4
So 1309982-38-4 is a valid CAS Registry Number.
1309982-38-4Relevant articles and documents
NOVEL SPIROCHROMANONE CARBOXYLIC ACIDS
-
Page/Page column 82-83, (2010/04/03)
The invention relates to a compound of a general formula (I): wherein A represents a linking group; Ar1 represents a group formed from an aromatic ring; R1 and R2 each independently represent a hydrogen atom, a halogen atom, a cyano group, a C2-C6 alkenyl group, a C1-C6 alkoxy group, a halo-C1-C6 alkoxy group, a cyclo-C3-C6 alkyloxy group, a C2-C7 alkanoyl group, a halo-C2-C7 alkanoyl group, a C2-C7 alkoxycarbonyl group, a halo-C2-C7 alkoxycarbonyl group, a cyclo-C3-C6 alkyloxycarbonyl group, an aralkyloxycarbonyl group, a carbamoyl-C1-C6 alkoxy group, a carboxy-C2-C6 alkenyl group, or a group of -Q1-N(Ra)-Q2-Rb; a C1-C6 alkyl group optionally having substituent(s); an aryl or heterocyclic group optionally having substituent(s); or a C1-C6 alkyl group or a C2-C6 alkenyl group having the aryl or heterocyclic group; T and U each independently represent a nitrogen atom or a methine group; and V represents an oxygen atom, a sulfur atom or an imino group. The compound of the invention is useful as therapeutical agents for various ACC-related diseases.
